Supplementary Materials and Methods
DNA Constructs VAPA-GFP and VAPA(K87D/M89D)-GFP were provided by Axel Brunger via Addgene (Addgene plasmids 18874 and 18875, respectively). VAPB-GFP has been previously described (1) . From these initial constructs, VAPB-mRuby2, VAPB-Clover, and VAPA-paGFP were created using standard DNA manipulation techniques.
For the proximity biotinylation experiments AMIGO-YFP-APEX was generated from the APEX2-NES vector obtained from Alice Ting (Addgene plasmid # 49386). Overlap PCR was used to insert an EcoRI cut site (5'GACGGAGAATTCAAGGGATGGACTACAAGGATGAC3') in the APEX2-NES vector at the 5' end of APEX2 allowing the resulting XbaI and EcoRI APEX DNA to be added to the 3' end of AMIGO-YFP to form AMIGO-YFP-APEX.
pcDNA3.1-Clover-mRuby2 was a gift from Kurt Beam (Addgene plasmid # 49089), mRuby2-C1 was from Michael Davidson (Addgene plasmid # 54768) and pcDNA3-Clover was from Michael Lin (Addgene plasmid # 40259). An mClover-C1 construct was generated by digesting pcDNA3-Clover and mRuby2-C1 with NdeI and BsrGI and exchanging Ruby2 with Clover. Ruby2-Kv2.1 was generated from mRuby2-C1 and the previously described GFP-Kv2.1 (2) by replacing the NheI to EcoRI GFP encoding fragment in GFP-Kv2.1 with mRuby2. CloverKv2.1 was generated from mClover-C1 and a Ruby2-Kv2.1 by inserting the XhoI to XmaI fragment containing Kv2.1 into mClover-C1.
Generation of the CD4-based chimeras relied heavily on synthetic DNA obtained from Genewiz. CD4-Kv2.1:445-609 was created using synthetic DNA (amino acids 445-609 of Kv2.1) which were appended to wildtype CD4 using SacII and NotI restriction sites. The CD4-Kv2.2:452-911 was made using the same approach. In both of these constructs the VAP binding motif was the same distance from the CD4 transmembrane domain. The other CD4 Kv2.1 minimal FFAT sequence constructs (see Fig. 7 ) were based on work done in the Bjorkman laboratory (3) , where the CD4 transmembrane domain was separated from the Kv2.1 channel sequence by using a combination of (Gly4Ser)n linkers, to confer flexibility, with β2-microglobulin sequence to provide a more rigid structure. β2-microglobulin is a monomeric 12 kD protein with an N-to C-termini separation distance of ~3.5 nanometers (4). The Gly4Ser linkers were of variable length so as to keep the total amino acid number from the CD4 transmembrane domain to the Kv2.1 FFAT motif consistent between the CD4-chimeric constructs and wildtype Kv2.1. For the oxysterol-binding protein (OSBP) FFAT motif (5) and flanker construct (CD4-OSBP(FFAT)), a single serine in the OSBP FFAT flanker region was changed to aspartic acid to a priori nullify any possible phosphorylation effects on VAP binding. All synthetic DNA segments were inserted into the CD4 backbone using SacII and XbaI restriction sites. All constructs terminated in a stop codon inserted into the sequence immediately after the last amino acid of interest.
The luminal ER marker dsRedER has been previously described (6, 7) . mCherry-JPH4 was provided by Yousang Gwack (Addgene 79599).
Microscopy Laser scanning confocal microscopy was performed using an Olympus FluoView 1000 inverted microscope equipped with two spectral detectors and one filter based detector in addition to an Ar laser (458/488/515 nm), 543 nm and 633 nm HeNe lasers and a 60X PlanApo, 1.4 NA, objective. Spinning disk confocal microscopy was performed using a Yokogawa-based CSUX1 system built around an Olympus IX83 inverted stand coupled to an Andor laser launch containing 405, 488, 561, and 637 nm diode lasers, 100-150 mW each. Images were collected using an Andor iXon EMCCD camera (DU-897) and 100X Plan Apo, 1.4 NA objective. This system is equipped with the ZDC constant focus system and a Tokai Hit chamber and objective heater. Unless stated otherwise, all images were acquired taken via spinning disk microscopy. When indicated, TIRF microscopy was performed on a Nikon Eclipse Ti fluorescence microscope with 405, 488, 561, and 633 nm diode lasers, 100 mW each, split evenly between TIRF and photoactivation unit pathways. However, 405 nm based activation of the photoactivatable GFP-VAPA presented in Fig. 5 was performed in TIRF to limit the activated GFP fluorescent to within 100 nm of the plasma membrane. TIRF images were collected using an Andor iXon EMCCD DU-897 camera through a Plan Apo 100x, NA 1.49, TIRF objective. Both the objective and dish are temperature controlled and z-drift was mitigated through the use of the Nikon Perfect-Focus system. With all three systems the appropriate use of spectral detectors, sequential excitation, dichroics and bandpass filters permitted fluorophore separation. Additional details regarding our microscopy have been previously described (6, 8, 9) . 
